scispace - formally typeset
Open AccessJournal Article

The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings

Reads0
Chats0
About
This article is published in The New England Journal of Medicine.The article was published on 1985-01-01 and is currently open access. It has received 3913 citations till now. The article focuses on the topics: TIMI & Thrombolysis.

read more

Citations
More filters
Journal ArticleDOI

Guidelines for the Early Management of Patients With Acute Ischemic Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

TL;DR: These guidelines supersede the prior 2007 guidelines and 2009 updates and support the overarching concept of stroke systems of care and detail aspects of stroke care from patient recognition; emergency medical services activation, transport, and triage; through the initial hours in the emergency department and stroke unit.
Journal ArticleDOI

A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease

TL;DR: The clinical and angiographic outcomes were better in patients who received a stent than in those who received standard coronary angioplasty, however, this benefit was achieved at the cost of a significantly higher risk of vascular complications at the access site and a longer hospital stay.
Journal ArticleDOI

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction

TL;DR: SK seems to be a safe drug for routine administration in acute myocardial infarction in patients admitted within 12 h after the onset of symptoms and with no contraindications to SK when randomised to receive SK in addition to usual treatment.
References
More filters
Journal ArticleDOI

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.

TL;DR: The results document the presence of a subepicardial zone of ischemic but viable myocardium which is available for pharmacologic or surgical salvage for at least three and perhaps six hours following circumflex occlusion in the dog.
Journal ArticleDOI

Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

TL;DR: The kinetic analysis suggested that the activation in the presence of fibrin occurs through binding of an activator molecule to the clot surface and subsequent addition of plasminogen (sequential ordered mechanism) to form a cyclic ternary complex.
Journal ArticleDOI

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

TL;DR: Bacterial clones containing human tissue-type plasminogen activator cDNA sequences were identified in a cDNA library prepared using gel-fractionated mRNA from human melanoma cells and a polypeptide was produced having the fibrinolytic properties characteristic of authentic human t-PA.
Journal Article

The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow

TL;DR: Eventual transmural necrosis, and therefore over-all infarct size was determined by, and can be predicted from flow measurements obtained shortly after coronary occlusion, and irreversible injury of ischemic myocardium developed as a transmural wavefront.

Kinetics of the Activation of Plasminogen by Human Tissue Plasminogen Activator

TL;DR: In this paper, the activation of Gluplasminogen and Lys-minminogen in the presence of fibrinogen (f) was studied in purified systems, and the initial rate of activation (u) was calculated.
Related Papers (5)